Quantcast

Latest Analgesics Stories

2014-03-20 23:02:05

The Firm is evaluating Tylenol lawsuits on behalf of individuals who sustained serious and life-threatening liver injuries, allegedly due to the acetaminophen in Tylenol brand over-the-counter medications. New York, New York (PRWEB) March 20, 2014 Dozens of Tylenol lawsuits (http://www.tylenollawsuitclaims.com/ ) that claim the popular over-the-counter medications caused serious liver injuries continue to move forward in a multidistrict litigation underway in U.S. District Court, Eastern...

2014-03-16 23:01:50

The firm is evaluating Tylenol lawsuits on behalf of individuals who suffered serious liver damage following ingestion of a Tylenol-brand product. New York, New York (PRWEB) March 16, 2014 As Tylenol lawsuits (http://www.tylenollawsuitclaims.com/) continue to move forward in U.S. Courts, Bernstein Liebhard LLP notes that a federal judge in New Jersey has ruled that a claim stemming from a 2009 Tylenol recall will be allowed to proceed. According to an Order issued on March 5, 2014, Judge...

2014-03-13 08:29:55

BRIDGEWATER, New Jersey, March 13, 2014 /PRNewswire/ -- Helsinn Group, the company focused on building quality cancer care, is pleased to announce today that its U.S. subsidiary, Helsinn Therapeutics (U.S.), Inc., has been named as one of the 100 best places to work in New Jersey in a survey and award program conducted by NJBIZ which recognizes and honors the state's top employers who show a dedication to their employees' growth and quality of life. In 2009 Helsinn...

2014-03-12 08:31:17

NEWARK, Calif., March 12, 2014 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO) today announced that the U.S. Food and Drug Administration (FDA) approved Mallinckrodt plc's New Drug Application (NDA) for XARTEMIS(TM) XR (oxycodone hydrochloride and acetaminophen) Extended-Release Tablets (CII), previously known as MNK-795, for the management of acute pain severe enough to require opioid treatment and in patients for whom alternative treatment options (e.g., non-opioid analgesics) are...

2014-03-12 08:30:24

Investigational Opioid Analgesic Incorporates Abuse-Deterrent Technology STAMFORD, Conn., March 12, 2014 /PRNewswire/ -- Purdue Pharma L.P. announced that a Phase 3 study of an investigational extended-release formulation of hydrocodone bitartrate met its primary efficacy endpoint by showing that patients with chronic low back pain treated with the once-daily analgesic agent experienced statistically significant reduction in pain compared with placebo (p=0.0016). This investigational...

2014-03-11 23:01:45

The Firm is now investigating Tylenol liver damage claims on behalf of individuals who were allegedly injured by a Tylenol brand product. New York, New York (PRWEB) March 11, 2014 Tylenol lawsuits (http://www.tylenollawsuitclaims.com/) filed on behalf of individuals who were allegedly injured by the popular over-the-counter medications continue to mount in a federal multidistrict litigation now underway in U.S. District Court, Eastern District of Pennsylvania, Bernstein Liebhard LLP...

2014-03-10 16:33:25

NEWARK, Calif., March 10, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that it will release fourth quarter fiscal year 2013 financial results after the market closes on Wednesday, March 12, 2014. The Company will host a conference call beginning at 4:30 pm Eastern time, 1:30 pm Pacific time to discuss its results. Participants can access the call by dialing 877-317-6789 (United States) or 412-317-6789 (international). The conference call will also be available...

2014-03-07 16:22:47

NASHVILLE, Tenn., March 7, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced that data from a recent study evaluating the efficacy and safety of Caldolor(®) (ibuprofen) Injection will be presented at the Pediatric Anesthesiology 2014 conference in Fort Lauderdale, Florida. The pediatric study met its primary endpoint demonstrating that Caldolor was associated with a statistically significant reduction in temperature within the first 2 hours of...

2014-02-26 23:27:54

National network of attorneys continues to provide complimentary consultations to consumers inquiring about legal options to seek compensation over allegations that Tylenol and other acetaminophens may cause liver damage. San Diego, Ca (PRWEB) February 26, 2014 http://www.resource4thepeople.com/defectivedrugs/acetaminophen.html Resource4thePeople announced today it is alerting consumers to a safety alert* issued by the Food and Drug Administration warning health care professionals to...

Zohydro FDA Approval Sparks Concerns From Several Groups
2014-02-26 13:58:12

Lee Rannals for redOrbit.com - Your Universe Online A group of 40 organizations have joined together to try and influence the Food and Drug Administration (FDA) to revoke its approval of the prescription drug Zohydro. The group of health care professionals and consumer and addiction treatment groups say they are “echoing the concerns” of members of Congress and the State Attorneys General regarding the FDA’s decision to approve Zohydro for use. “On behalf of consumer safety...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related